NIH Funding Opportunities

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)

(PA-17-248)
National Cancer Institute
Application Receipt/Submission Date: June 15, 2017 by 5:00 PM local time of applicant organization

Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)

(RFA-DE-18-004)
National Institute of Dental and Craniofacial Research
Application Receipt Date: June 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24)

(PAR-17-228)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 19, 2017, October 23, 2017, June 19, 2018, October 23, 2018, June 19, 2019, October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Genomics and Informatics Center for the SubPopulations and InteRmediate Outcomes Measures In COPD Study (SPIROMICS) (U24) 

(RFA-HL-18-011)
National Heart, Lung, and Blood Institute
Application Receipt Date: June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)

(RFA-MH-18-200)
National Institute of Mental Health
Application Receipt Dates: June 20, 2017, June 20, 2018, June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) 

(RFA-DA-18-005)
National Institute on Drug Abuse
Application Receipt Date: June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: National Swine Resource and Research Center (U42)

(PAR-17-255)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Dates: June 21, 2017, September 25, 2017 and January 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

National Cooperative Drug/Device Discovery/Development Groups (U01) 

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19) 

(PAR-17-186)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt/Submission Dates: June 23, 2017; October 23, 2017; February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)

(RFA-HL-17-023)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)

(RFA-HL-17-024)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)

(RFA-HL-17-025)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)

(RFA-HL-17-026)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)

(RFA-HL-17-027)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)

(RFA-HL-17-028)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)

(RFA-HL-17-029)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)

(RFA-HL-17-030)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)

(RFA-HL-17-031)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)

(RFA-HL-17-032)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)

(RFA-HL-17-033)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)

(RFA-HL-17-034)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Human-Animal Interaction (HAI) Research (R21)

(PAR-17-229)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Human-Animal Interaction (HAI) Research (R03)

(PAR-17-230)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Human-Animal Interaction (HAI) Research (R01)

(PAR-17-231)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)

(PAR-17-167)
National Cancer Institute
Application Receipt/Submission Dates: June 28, 2017; October 11, 2017; February 14, 2018, June 28, 2018; October 11, 2018; February 14, 2019; June 28, 2019; October 11, 2019; February 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Research Answers to NCI's Provocative Questions (R01)

(RFA-CA-17-017)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement

Research Answers to NCI's Provocative Questions (R21)

(RFA-CA-17-018)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement

Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01)

(RFA-CA-17-019)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)

(RFA-CA-17-020)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)

(RFA-CA-17-021)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)

(RFA-CA-17-022)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) 

(RFA-HD-18-019)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R21)

(RFA-HD-18-020)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Centers of Excellence for Training in Glycosciences (K12)

(RFA-HL-18-013)
National Heart, Lung, and Blood Institute
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

National Centers for Cryoelectron Microscopy (U24)

(RFA-RM-17-002)
NIH Roadmap Initiatives
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Environmental influences on Placental Origins of Development (ePOD) (R01)

(RFA-ES-17-005)
National Institute of Environmental Health Sciences
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Data Coordinating Center for the NICHD Neonatal Research Network (U24)

(RFA-HD-18-010)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01)

(RFA-HD-18-002)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43) 

(RFA-HD-18-028)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization

Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp)

(PA-17-286)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: June 30, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDCR Dental Specialty and PhD Program (DSPP)(K12)

(RFA-DE-18-003)
National Institute of Dental and Craniofacial Research
Application Receipt Date: July 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)

(PAR-17-236)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: July 5, 2017 (renewal, resubmission, revision); October 5, 2017 (new) and November 5, 2017 (renewal, resubmission, revision); June 5, 2018 (new) and July 5, 2018 (renewal, resubmission, revision); October 5, 2018 (new) and November 5, 2018 (renewal, resubmission, revision); June 5, 2019 (new) and July 5, 2019 (renewal, resubmission, revision); October 5, 2019 (new) and November 5, 2019 (renewal, resubmission, revision), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)

(RFA-HL-18-014)
National Heart, Lung, and Blood Institute
Application Receipt Date: July 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates

PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)

(PAR-17-257)
National Institute of Mental Health
Application Receipt/Submission Dates: July 6, 2017, June 6, 2018, June 6, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (Collaborative U01)

(PAR-17-258)
National Institute of Mental Health
Application Receipt/Submission Dates: July 6, 2017, June 6, 2018, June 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44)

(RFA-CA-17-024)
National Cancer Institute
Application Receipt Date: July 6, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Integrative Computational Biology for Analysis of NHLBI TOPMed Data

(RFA-HL-18-020)
National Heart, Lung, and Blood Institute
Application Receipt Dates: July 6, 2017 and July 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)

(RFA-AR-18-005)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: July 10, 2017, by 5:00 PM local time of applicant organization. Late applications will not be accepted

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

(PAR-17-234)
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Nursing Research
Office of Research on Women's Health
Application Receipt/Submission Dates: July 11, 2017, July 11, 2018, July 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21)

(PAR-17-235)
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Office of Research on Women's Health
Application Receipt/Submission Dates: July 11, 2017, July 11, 2018, July 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)

(PAR-17-274)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: July 11, 2017 and then Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Genomic Community Resources (U24)

(PAR-17-273)
National Human Genome Research Institute
National Cancer Institute
Application Receipt/Submission Date: The first due date is July 13, 2017; Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)

(RFA-DK-17-507)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date: July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)

(RFA-DK-17-508)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date: July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54)

(RFA-OD-17-002)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
Food and Drug Administration
National Institute on Drug Abuse
Office of Disease Prevention
Application Receipt Date: July 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)

(RFA-OD-17-003)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
Food and Drug Administration
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date: July 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)

(RFA-OD-17-006)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date: July, 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Alzheimer's-related Resource Centers for Minority Aging Research (AD-RCMAR) (P30)

(RFA-AG-18-002)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Resource Centers for Minority Aging Research (P30)

(RFA-AG-18-003)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24)

(RFA-AG-18-004)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Cystic Fibrosis Research and Translation Center (P30)

(RFA-DK-17-007)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NINR Clinical Trial Planning Grant (R34)

(PAR-17-133)
National Institute of Nursing Research
Application Receipt/Submission Dates: July 24, 2017, November 24, 2017, March 23, 2018, July 24, 2018, November 26, 2018, March 25, 2019, July 24, 2019, November 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Research Education Program Grants for CryoEM Curriculum Development (R25)

(RFA-RM-17-004)
NIH Roadmap Initiatives
National Eye Institute
Application Receipt Date: July 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

(RFA-DA-18-003)
National Institute on Drug Abuse
Application Receipt Dates: July 25 2017; July 25, 2018; July 25, 2019; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp)

(PA-17-143)
National Cancer Institute
Application Receipt/Submission Dates: July 25, 2017; and December 12, 2017, by 5:00 PM local time of applicant organization

Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24)

(RFA-MH-18-250)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: July 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Data Coordinating Center (U24)

(RFA-MH-18-251)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: July 26,2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

SBIR E-learning for HAZMAT and Emergency Response (R43/R44) 

(RFA-ES-17-004)
National Institute of Environmental Health Sciences
Application Receipt Date: July 28, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)

(RFA-DA-18-001)
National Institute on Drug Abuse
Application Receipt Dates: July 31, 2017, July 31, 2018, July 31, 2019, by 5:00 PM local time of applicant organization

Cellular Therapies for Treatment of Radiation Injuries (U01) 

(RFA-AI-17-001)
National Institute of Allergy and Infectious Diseases
Application Receipt Date: August 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)

(RFA-AI-17-010)
National Institute of Allergy and Infectious Diseases
Application Receipt Date: August 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Innovation for HIV Vaccine Discovery (R01)

(PAR-17-263)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: August 1, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Centers for AIDS Research (P30)

(PAR-17-237)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt/Submission Dates: August 1, 2017; August 17, 2018; August 17, 2019 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Developmental Centers for AIDS Research (P30)

(PAR-17-238)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt/Submission Dates: August 1, 2017; August 17, 2018; August 17, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)

(RFA-AT-18-001)
National Center for Complementary and Integrative Health
Application Receipt Date: August 4, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Regional Consortia for High Resolution Cryoelectron Microscopy (U24)

(RFA-GM-17-005)
National Institute of General Medical Sciences
Application Receipt Date: August 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (PRECluDE) (U01)

(RFA-HL-18-007)
National Heart, Lung, and Blood Institute
Application Receipt Date: August 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34)

(PAR-17-268)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: August 7, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)

(PAR-17-187)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)

(PAR-17-188)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01)

(PAR-17-189)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)

(RFA-AR-18-002)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Dates: August 7, 2017; December 4, 2017; April 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R21)

(RFA-AR-18-003)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Sleep Health and Circadian Biology in HIV-Related Comorbidities (R01)

(RFA-HL-18-005)
National Heart, Lung, and Blood Institute
Application Receipt Date: August 9, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

(PAR-17-201)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: August 9, 2017, Feb 6, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)

(PAR-17-205)
National Institute of Neurological Disorders and Stroke
NIH Blueprint for Neuroscience Research
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Application Receipt/Submission Dates: August 9, 2017, Feb 7, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Palliative Care Research Cooperative (PCRC) (U2C)

(RFA-NR-17-001)
National Institute of Nursing Research
Application Receipt Date: August 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44)

(RFA-DA-18-010)
National Institute on Drug Abuse
Application Receipt Date: August 15, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Extracellular Vesicles and Substance Use Disorders (R21)

(PAR-17-242)
National Institute on Drug Abuse
Application Receipt/Submission Dates: August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Extracellular Vesicles and Substance Use Disorders (R01)

(PAR-17-250)
National Institute on Drug Abuse
Application Receipt/Submission Dates: August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Inter-organelle Communication in Cancer (R01)

(PAR-17-203)
National Cancer Institute
Application Receipt/Submission Dates: August 16, 2017; January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Inter-organelle Communication in Cancer (R21)

(PAR-17-204)
National Cancer Institute
Application Receipt/Submission Dates: August 16, 2017, January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01)

(RFA-DA-18-008)
National Institute on Drug Abuse
Application Receipt Date: August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21)

(RFA-DA-18-009)
National Institute on Drug Abuse
Application Receipt Date: August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Tobacco Regulatory Science (R01)

(RFA-OD-17-007)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Regulatory Science Small Grant Program for New Investigators (R03)

(RFA-OD-17-008)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Regulatory Science (R21)

(RFA-OD-17-009)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3)

(RFA-NS-17-023)
National Institute of Neurological Disorders and Stroke
Application Receipt Date: August 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late Applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)

(RFA-DA-18-002)
National Institute on Drug Abuse
Application Receipt Dates: August 22, 2017; August 22, 2018; August 22, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Nasal Delivery of CNS Therapeutics (R43/R44) 

(RFA-DA-18-006)
National Institute on Drug Abuse
Application Receipt Date: August 23, 2017, by 5:00 PM local time of applicant organization

Nasal Delivery of CNS Therapeutics (R41/R42) 

(RFA-DA-18-007)
National Institute on Drug Abuse
Application Receipt Date: August 23, 2017, by 5:00 PM local time of applicant organization

Lasker Clinical Research Scholars Program Si2/R00

(PAR-17-254)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Application Receipt/Submission Date: August 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

NIH Director's Pioneer Award Program (DP1)

(RFA-RM-17-005)
NIH Roadmap Initiatives
The Common Fund/Office of Strategic Coordination
Application Receipt Date: September 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)

(RFA-MH-18-300)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date: September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21)

(RFA-MH-18-301)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date: September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIH Director's New Innovator Award Program (DP2)

(RFA-RM-17-006)
NIH Roadmap Initiatives
Application Receipt Date: September 8, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)

(PAR-17-128)
National Cancer Institute
Application Receipt/Submission Date: September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)

(PAR-17-129)
National Cancer Institute
Application Receipt/Submission Date: September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) 

(RFA-TR-17-002)
National Center for Advancing Translational Sciences
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) 

(RFA-TR-17-003)
National Center for Advancing Translational Sciences
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No Late applications will be accepted for this FOA

NIH Director's Transformative Research Awards (R01)

(RFA-RM-17-007)
NIH Roadmap Initiatives
The Common Fund/Office of Strategic Coordination
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) 

(PAR-17-146)
National Cancer Institute
Application Receipt/Submission Date: September 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIH Director's Early Independence Awards (DP5)

(RFA-RM-17-008)
NIH Roadmap Initiatives
Application Receipt Date: September 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

NIH StrokeNet Regional Coordinating Stroke Centers (U24)

(PAR-17-276)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Research Education: Bridges to the Doctorate (R25)

(PAR-17-209)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Bridges to the Baccalaureate Program (R25)

(PAR-17-210)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)

(PA-17-247)
Agency for Healthcare Research and Quality
Application Receipt/Submission Dates: September 25, 2017, September 25, 2018, and September 26, 2019), by 5:00 PM local time of applicant organization

NIDA Core "Center of Excellence" Grant Program (P30)

(PAR-17-121)
National Institute on Drug Abuse
Application Receipt/Submission Dates: September 26, 2017; September 26, 2018, September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Perception and Cognition Research to Inform Cancer Image Interpretation (R21)

(PAR-17-124)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Perception and Cognition Research to Inform Cancer Image Interpretation (R01)

(PAR-17-125)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01)

(RFA-DE-18-005)
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R21)

(RFA-DE-18-006)
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Novel Cell Non-autonomous Mechanisms of Aging (R01)

(RFA-AG-18-009)
National Institute on Aging
Application Receipt Date: October 3, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Maximizing Investigators' Research Award for Early Stage Investigators (R35)

(PAR-17-190)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 3, 2017; October 3, 2018; October 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NIAMS Rheumatic Diseases Research Resource-based Centers (P30)

(RFA-AR-18-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: October 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01)

(PAR-17-215)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: October 3, 2017; February 2, 2018; June 1, 2018; October 3, 2018; February 1, 2019; May 31, 2019; October 3, 2019; and January 31, 2020
Resubmission, Revision, and Renewal Applications: October 18, 2017, February 20, 2018, June 14, 2018, October 17, 2018, February 15, 2019, June 14, 2019, October 17, 2019, February 14, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)

(PAR-17-093)
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: October 3, 2017; March 1, 2018; June 7, 2018; October 3, 2018; March 1, 2019; June 7, 2019; October 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24)

(PAR-17-172)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: October 6, 2017; June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and Revision Applications: June 21, 2018, February 21, 2019, and October 21, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3)

(PAR-17-174)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: October 6, 2017; June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and revision Applications: June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01)

(PAR-17-216)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: October 6, 2017; June 7, 2018; February 7, 2019; and October 8, 2019
Resubmission, Revision, and Renewal Applications: October 20, 2017; June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Basic Research in Calcific Aortic Valve Disease (R01) 

(RFA-HL-18-010)
National Heart, Lung, and Blood Institute
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)

(PAR-17-184)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Dates: October 18, 2017; June 19, 2018; February 20, 2019; October 18, 2019; June 18, 2020; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34) 

(RFA-HL-18-008)
National Heart, Lung, and Blood Institute
Application Receipt Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01)

(RFA-HL-18-009)
National Heart, Lung, and Blood Institute
Application Receipt Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01) 

(PAR-17-294)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)

(RFA-AG-18-006)
National Institute on Aging
Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Coordinating Center for Claude D. Pepper Older Americans Independence Centers (U24)

(RFA-AG-18-008)
National Institute on Aging
Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Uncovering the Causes, Contexts, and Consequences of Elder Mistreatment (R01)

(RFA-AG-18-010)
National Institute on Aging
Application Receipt Date: October 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention and Care (R18)

(RFA-DK-17-008)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: October 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Psychological, Behavioral, and Neurocognitive-Focused Ancillary Studies to the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) (U01)

(RFA-DK-17-009)
National Institute of Diabetes and Digestive and Kidney Diseases
Office of Behavioral and Social Science Research
Application Receipt Date: October 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDDK Central Repositories Non-renewable Sample Access (X01)

(PAR-17-270)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: October 31, 2017; March 2, 2018; June 29, 2018; October 30, 2018; March 1, 2019; June 28, 2019; October 31, 2019; March 3, 2020; and June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

George M. O'Brien Kidney Research Core Centers (P30)

(RFA-DK-17-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: November 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)

(PAR-17-178)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)

(PAR-17-177)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)

(PAR-17-180)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)

(RFA-DK-17-006)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01)

(RFA-MH-18-400)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Office of Behavioral and Social Science Research
Application Receipt Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)

(PAR-17-293)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. ***This FOA is being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. This FOA will be reissued for additional due date(s) on or after January 25, 2018.***. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)

(PA-17-138)
National Cancer Institute
Application Receipt/Submission Dates: November 8, 2017; March 28, 2018, by 5:00 PM local time of applicant organization

Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)

(RFA-DA-18-004)
National Institute on Drug Abuse
Application Receipt Dates: Nov 13, 2017; Nov 13, 2018, Nov 13, 2019 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Innovative Research in Cancer Nanotechnology (IRCN) (R01)

(PAR-17-240)
National Cancer Institute
Application Receipt/Submission Dates: November 21, 2017; May 23, 2018; November 20, 2018; May 23, 2019, November 21, 2019, May 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01)

(RFA-DE-18-008)
National Institute of Dental and Craniofacial Research
Application Receipt Date: November 24,2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

HIV pathogenesis and the oral microbiota (R01)

(RFA-DE-18-007)
National Institute of Dental and Craniofacial Research
Application Receipt Date: November 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement

Specialized Alcohol Research Centers (P50) 

(RFA-AA-18-001)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date: December 5, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Silencing of HIV-1 Proviruses (R61/R33)

(RFA-AI-17-013)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date: December 6, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Maximizing Investigators' Research Award (R35)

(PAR-17-094)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 17, 2018; May 17, 2018; January 17, 2019; May 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33)

(PAR-17-162)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates: February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017; February 14, 2018; October 17, 2018; June 14, 2019

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3)

(PAR-17-175)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: February 2, 2018; October 3, 2018; May 31, 2019; and January 31, 2020
Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)

(PAR-17-206)
National Cancer Institute
Application Receipt/Submission Dates: February 7, 2018; June 8, 2018; February 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24)

(PAR-17-173)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: October 3, 2018; May 31, 2019; and January 31, 2020
Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) 

(PAR-17-141)
Food and Drug Administration
Application Receipt/Submission Dates: February 15, 2018, February 15, 2019, by 11:59 PM Eastern Time

Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71)

(PAR-17-097)
John E. Fogarty International Center
Application Receipt/Submission Dates: March 14, 2018; March 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Data Science Research: Personal Health Libraries for Consumers and Patients (R01)

(PAR-17-159)
National Library of Medicine
Application Receipt/Submission Dates: March 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

(PAR-17-099)
National Eye Institute
Application Receipt/Submission Dates: March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

IDeA Networks of Biomedical Research Excellence (INBRE) (P20)

(PAR-17-160)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

NCMRR Early Career Research Award (R03)

(PAR-17-161)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)

(PAR-17-163)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Application Receipt/Submission Dates: March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) 

(PAR-17-151)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)

(PAR-17-150)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Environmental Health Sciences Core Centers (EHS CC) (P30)

(RFA-ES-17-003)
National Institute of Environmental Health Sciences
Application Receipt Dates: April 17, 2018, April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18)

(RFA-FD-17-010)
Food and Drug Administration
Application Receipt Date: April 17, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA

International Research in Infectious Diseases, including AIDS (R01) 

(PAR-17-142)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: May 22, 2018; May 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25) 

(PAR-17-221)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50)

(PAR-17-168)
National Institute of Mental Health
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NICHD Research Education Programs (R25)

(PAR-17-183)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: May 25, 2018; May 25, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32)

(PAR-17-096)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute on Drug Abuse
National Institute of General Medical Sciences
National Institute of Mental Health
Application Receipt/Submission Dates: May 25, 2018; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)

(PAR-17-249)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)

(PAR-17-208)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date